Key result
Higher SPISE linked to ~21% lower odds of hypertension per unit increment across glycemic strata.
Why the study?
The relationship between the single-point insulin sensitivity estimator (SPISE) and hypertension, and whether it depends on glycemic status, remained unclear.
Is a higher single-point insulin sensitivity estimator (SPISE) associated with lower odds of prevalent hypertension among US adults across different glycemic statuses?
Cross-Sectional (n=27,563)
Is a higher single-point insulin sensitivity estimator (SPISE) associated with lower odds of prevalent hypertension among US adults across different glycemic statuses?
Answers are grounded in this paper and cite their sources.
A higher single-point insulin sensitivity estimator (SPISE) is independently and nonlinearly associated with lower odds of prevalent hypertension in US adults, regardless of whether they have normoglycemia, prediabetes, or diabetes.
The single-point insulin sensitivity estimator (SPISE) is a validated surrogate for insulin sensitivity derived from triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), and body mass index (BMI). Its relationship with hypertension, and whether that relationship depends on glycemic status, remains unclear. We examined the association between SPISE and hypertension among United States adults. This study analyzed data from 27,563 adults aged 20 to 85 years (mean age 49.0 ± 17.7 years, 49.6% men) who participated in seven consecutive cycles of the National Health and Nutrition Examination Survey from 2005 to 2018. SPISE was calculated as 600 × HDL-C 0.185 / (TG 0.2 × BMI 1.338 ), with HDL-C and TG in mg/dL and BMI in kg/m². Hypertension was ascertained from measured blood pressure, self-reported physician diagnosis, or antihypertensive medication use. The association was assessed using logistic regression across three progressively adjusted models, with SPISE entered both continuously and in quartiles. Restricted cubic splines (RCS) and piecewise regression characterized the dose-response relationship, and analyses were stratified by glycemic status with a formal test of interaction. Hypertension was present in 12,430 participants (45.1%). Higher SPISE was associated with lower odds of hypertension in every model, with a fully adjusted odds ratio of 0.79 (95% CI 0.78 to 0.80) per one-unit increment and 0.26 (95% CI 0.24 to 0.29) for the highest quartile, showing a significant trend across quartiles. RCS revealed a nonlinear pattern, and piecewise regression identified an exploratory inflection point at a SPISE of 5.025, below which the inverse association was steeper. The association was of similar magnitude in normoglycemia, prediabetes, and diabetes (odds ratio 0.82 in each stratum), and the formal interaction test did not support effect modification by glycemic status (P for interaction = 0.933). Higher SPISE was independently associated with lower odds of prevalent hypertension, and this association was consistent across the glycemic spectrum. Prospective studies are needed to establish the temporal nature of this association.
No takes yet. Share an insight, caveat, or question.
Fuad A. Abdu (2026) conducted a cross-sectional in Hypertension (n=27,563). Single-point insulin sensitivity estimator (SPISE) vs. Lower SPISE values / lowest quartile was evaluated on Prevalent hypertension (OR 0.79, 95% CI 0.78-0.80). Higher single-point insulin sensitivity estimator (SPISE) was associated with lower odds of hypertension across glycemic strata.
Synapse has enriched 10 related papers. Consider them for comparative context: